Highest-materiality recent filing
Kettner Investments acquires control via Series C Preferred Stock transfer from Juniper & Ivy and Medical Marijuana, Inc.
AXIM issues $814,555 in convertible notes and restricted stock for past-due compensation
Issued $814,555 convertible notes to directors, officers, contractors, and Sapphire employees to settle past salaries/fees.
AXIM Biotechnologies settles IMS litigation; to issue 20M restricted shares plus cash and royalties
Settlement with Innovative Medical Supplies resolves two lawsuits; no admission of wrongdoing.
effective October 14, 2024, Juniper, the record holder of all 500,000 shares of Series C Preferred Stock issued and outstanding, which shares are exclusively entitled to fill any vacancy of a Series C Director seat, appointed Catalina Valencia to fill the Series C Director vacancy
Due to the fact that the Company's President and CEO, John W. Huemoeller II, was unable to serve as an officer of the Company as a result of serious illness
On October 12, 2024, President and Series C Director, John W. Huemoeller II died as a result of his illness.
on October 9, 2024, the Company’s board of directors appointed Catalina Valencia as the Company’s new President.
Max materiality 0.80 · Median 0.60 · Most common event other_material